{"id":3165,"date":"2025-02-05T18:50:53","date_gmt":"2025-02-05T17:50:53","guid":{"rendered":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/?p=3165"},"modified":"2025-02-05T19:05:02","modified_gmt":"2025-02-05T18:05:02","slug":"decentralized-clinical-trials","status":"publish","type":"post","link":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/","title":{"rendered":"Enhancing Medical Trials: Digital Decentralized Clinical Trials"},"content":{"rendered":"\n

Tomorrow\u2019s healthcare isn’t just about the transformation into a fully digitized and interconnected system; it\u2019s also about nurturing, approving, and implementing innovative digital medical products. To gain market approval, innovators must provide robust evidence demonstrating effectiveness, performance, data protection, security, and interoperability. Currently, the biggest hurdle isn’t just the stringent evidence requirements; it\u2019s how we collect that data. Traditional clinical studies may not be the best fit for digital medical products. Instead, the future of clinical trials is digital and decentralized. Here’s an overview of the key characteristics of clinical studies, multicenter clinical studies, and dezentralized clinical trials:<\/p>\n\n\n\n

<\/td>Clinical Studies<\/strong><\/td>Multicenter Studies<\/strong><\/td>Digital Decentralized <\/strong>
Clinical Trials<\/strong><\/td><\/tr>
Location<\/strong><\/td>Conducted at specific
study centers<\/strong>, with
fewer study centers
available for rare diseases<\/td>		Conducted at multiple <\/strong>
study<\/strong> centers <\/strong>across
regions<\/td>		Conducted remotely<\/strong>,
often at participants’
homes<\/td><\/tr>
Data Collection<\/strong>
& Evaluation<\/strong><\/td>		Manual data collection<\/strong>,
paper based or using site
specific electronic
systems at hospitals,
research facilities
or other clinical
institutions; on site visits<\/td>		Combination of manual <\/strong>
and electronic data <\/strong>
collection across sites<\/strong>,
often requiring site visits<\/td>		Automated data collection<\/strong>
via apps\/devices;
real-time, <\/strong>
location-independent <\/strong>
access<\/strong> to data through
a study management
system<\/td><\/tr>
Participant <\/strong>
Engagement<\/strong><\/td>		In-person visits<\/strong>
required; participants
must be willing to travel<\/td>		Primarily in-person visits<\/strong>
at various centers, some
remote elements possible<\/td>		Virtual visits<\/strong>, using
digital tools<\/td><\/tr>
Recruitment<\/strong><\/td>Limited to local <\/strong>
populations<\/strong>; recruitment
of test subjects
on-site through referrals
or advertisements<\/td>		Broader reach due to
multiple centers, but still
site-specific recruitment<\/strong><\/td>		Broader reach through
online platforms,
including diverse <\/strong>
populations<\/strong><\/td><\/tr>
Regulatory <\/strong>
Compliance<\/strong><\/td>		Well-established <\/strong>
processes<\/strong><\/td>		Established processes<\/strong>
across multiple sites, with
local adaptations<\/td>		Evolving regulations<\/strong>,
requiring new
compliance strategies<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Digital, decentralized clinical trials enhance traditional clinical trials without replacing them. They simplify study participation by moving the trial to the participant\u2019s immediate surroundings: their home.<\/p>\n\n\n\n

Here are five key advantages of Decentralized Clinical Trials (DCTs):<\/p>\n\n\n\n

1. Participants: Less effort and more engagement <\/strong><\/h2>\n\n\n\n

DCTs tend to achieve higher participant acceptance compared to traditional clinical studies, where 30% of all participants end up dropping out <\/a>(Cassidy-Soto et al., 2021).<\/a> One key factor is the reduced effort required from both participants and trial centers. Since 70% of participants live more than two hours away from the trial center, it is mandatory for participants in traditional clinical trials to be willing to travel (ibid.)<\/a>. Participants of DCTs save time and energy by avoiding long journeys, which is particularly beneficial for those in remote areas.<\/p>\n\n\n\n

Furthermore, instead of having a single orientation session at the trial’s outset, DCTs provide ongoing information throughout the study. This continuous communication fosters greater engagement and enhances compliance among participants, while also reducing the risk of drop-out.<\/p>\n\n\n\n

2. Recruiting: Larger participant pool and greater diversity<\/strong><\/h2>\n\n\n\n

80% of traditional clinical trials are delayed or terminated due to recruitment problems (Desai, 2020)<\/a>. That\u2019s what DCTs leverage: Location independence facilitates easier participant recruitment, significantly expanding the pool of possible test subjects from the outset. Since distance between participants and the study center is no longer a factor in selection, it allows for a more diverse group of individuals. Another plus: Since patients can register from home and submit their data digitally, the hurdles to participation are reduced, too.<\/p>\n\n\n\n

3. Costs: Lower Investments Required for Market Entry<\/strong><\/h2>\n\n\n\n

DCTs play a key role in reducing the average costs associated with the market entry of a medical device. Because they are essential for generating the necessary evidence, clinical studies represent a significant investment prior to market launch. By streamlining the recruiting and registration process, speeding up data collection, reducing personnel costs, and eliminating the need for on-site management, the digitalization of clinical trials tremendously reduces the average cost for the market launch of a medical product.<\/p>\n\n\n\n

4. Time: More time for research, and less for administration<\/strong><\/h2>\n\n\n\n

New medical products typically require a long time to make it to market. While DCTs don\u2019t fundamentally alter this reality, they do significantly reduce the time and effort needed for essential studies, ultimately benefiting the research team. DiMasi et al. (2022)<\/a> recently showed that DCTs can reduce the overall duration of clinical trials by 10%.<\/p>\n\n\n\n

Study management systems like DPM.research<\/a> eliminate redundant data administration processes by ensuring that patient data is collected just once. This data is then accessible through the central platform, allowing for on-demand access \u2013 location-independent and across multiple processes. During a DCT, the clinical investigator and a virtual support team continuously collect data, allowing them to supervise participants closely without the need for time-consuming on-site visits. In sum, DCTs enhance the care provided to study participants while simultaneously simplifying and increasing the efficiency of researchers’ work.<\/a><\/p>\n\n\n\n

5. Data Quality: Precise, standardized, driving better outcomes<\/strong><\/h2>\n\n\n\n

DCTs rely on standardized processes, resulting in enhanced connectivity and improved data flow among all stakeholders. The recruitment of test subjects is data-driven, resulting in a more targeted selection and enrollment process. Data is synchronized continuously and in real-time, allowing medical device manufacturers to gain a deeper understanding of how their products impact health and well-being.<\/p>\n\n\n\n

Although DCTs provide significant advantages over traditional clinical trials, they also face specific regulatory compliance challenges that need to be addressed for successful implementation. Learn more in our guide to Data Protection in Clinical Trials: Privacy and Compliance.<\/a><\/p>\n\n\n\n

\n\n\n\n

Image copyright: iStock\/NanoStockk<\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Tomorrow\u2019s healthcare isn’t just about the transformation into a fully digitized and interconnected system; it\u2019s also about nurturing, approving, and implementing innovative digital medical products. To gain market approval, innovators must provide robust evidence demonstrating effectiveness, performance, data protection, security, and interoperability. Currently, the biggest hurdle isn’t just the stringent evidence requirements; it\u2019s how we […]<\/p>\n","protected":false},"author":12,"featured_media":3234,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[39,49],"tags":[],"coauthors":[64],"class_list":["post-3165","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-digital-health","category-medical-data-space"],"yoast_head":"\nEnhancing Medical Trials: Digital Decentralized Clinical Trials - SMART SENSING insights<\/title>\n<meta name=\"description\" content=\"Decentralized clinical trials streamline market approval for medical products. Why? Have a look at the key advantages of DCTs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Enhancing Medical Trials: Digital Decentralized Clinical Trials - SMART SENSING insights\" \/>\n<meta property=\"og:description\" content=\"Decentralized clinical trials streamline market approval for medical products. Why? Have a look at the key advantages of DCTs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"SMART SENSING insights\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/FraunhoferIIS\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-05T17:50:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-05T18:05:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-content\/uploads\/2025\/02\/MobileHealthLab.png\" \/>\n\t<meta property=\"og:image:width\" content=\"4168\" \/>\n\t<meta property=\"og:image:height\" content=\"2085\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Christian Weigand\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Christian Weigand\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/decentralized-clinical-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/decentralized-clinical-trials\\\/\"},\"author\":{\"name\":\"Christian Weigand\",\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/#\\\/schema\\\/person\\\/1405236bfeefdc436a77e1cbc1e5a80f\"},\"headline\":\"Enhancing Medical Trials: Digital Decentralized Clinical Trials\",\"datePublished\":\"2025-02-05T17:50:53+00:00\",\"dateModified\":\"2025-02-05T18:05:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/decentralized-clinical-trials\\\/\"},\"wordCount\":867,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/decentralized-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/MobileHealthLab.png\",\"articleSection\":[\"Digital Health\",\"Medical Data Space\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/decentralized-clinical-trials\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/decentralized-clinical-trials\\\/\",\"url\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/decentralized-clinical-trials\\\/\",\"name\":\"Enhancing Medical Trials: Digital Decentralized Clinical Trials - SMART SENSING insights\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/decentralized-clinical-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/decentralized-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/MobileHealthLab.png\",\"datePublished\":\"2025-02-05T17:50:53+00:00\",\"dateModified\":\"2025-02-05T18:05:02+00:00\",\"description\":\"Decentralized clinical trials streamline market approval for medical products. Why? Have a look at the key advantages of DCTs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/decentralized-clinical-trials\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/decentralized-clinical-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/decentralized-clinical-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/MobileHealthLab.png\",\"contentUrl\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/MobileHealthLab.png\",\"width\":4168,\"height\":2085,\"caption\":\"illustration of decentralized clinical trials\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/decentralized-clinical-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Enhancing Medical Trials: Digital Decentralized Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/#website\",\"url\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/\",\"name\":\"SMART SENSING insights\",\"description\":\"learn more about our focus research areas sensor technology, electronics, and artificial intelligence\",\"publisher\":{\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/#organization\",\"name\":\"Fraunhofer IIS\",\"url\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Fraunhofer-IIS-1.png\",\"contentUrl\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Fraunhofer-IIS-1.png\",\"width\":826,\"height\":299,\"caption\":\"Fraunhofer IIS\"},\"image\":{\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/FraunhoferIIS\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/fraunhofer-iis\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/#\\\/schema\\\/person\\\/1405236bfeefdc436a77e1cbc1e5a80f\",\"name\":\"Christian Weigand\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/Weigand-Christian-0907-Glasow_1zu1-scaled-96x96.jpga850c8def151022934da8ec6725bb4c8\",\"url\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/Weigand-Christian-0907-Glasow_1zu1-scaled-96x96.jpg\",\"contentUrl\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/Weigand-Christian-0907-Glasow_1zu1-scaled-96x96.jpg\",\"caption\":\"Christian Weigand\"},\"description\":\"Christian is an expert in computer science and digital health, specialized in interoperability of medical devices, DiGA \\\/ DTx applications, and hospital information systems. He is head of the Fraunhofer IIS Mobile Health Lab. He has previously served as CTO at the Medical Valley Digital Health Application Center (dmac) for 6 years. Further affiliations include the National Coordination Office for Interoperability @gematik \\\/ Interop Council, DGBMT working group mHealth, and the Cybermed expert group at the Alliance for Cybersecurity.\",\"sameAs\":[\"https:\\\/\\\/orcid.org\\\/0000-0002-7542-994X\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/christian-weigand-7b710993\\\/\"],\"url\":\"https:\\\/\\\/websites.fraunhofer.de\\\/smart-sensing-insights\\\/author\\\/christian-weigand\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enhancing Medical Trials: Digital Decentralized Clinical Trials - SMART SENSING insights","description":"Decentralized clinical trials streamline market approval for medical products. Why? Have a look at the key advantages of DCTs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/","og_locale":"en_US","og_type":"article","og_title":"Enhancing Medical Trials: Digital Decentralized Clinical Trials - SMART SENSING insights","og_description":"Decentralized clinical trials streamline market approval for medical products. Why? Have a look at the key advantages of DCTs.","og_url":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/","og_site_name":"SMART SENSING insights","article_publisher":"https:\/\/www.facebook.com\/FraunhoferIIS","article_published_time":"2025-02-05T17:50:53+00:00","article_modified_time":"2025-02-05T18:05:02+00:00","og_image":[{"width":4168,"height":2085,"url":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-content\/uploads\/2025\/02\/MobileHealthLab.png","type":"image\/png"}],"author":"Christian Weigand","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Christian Weigand","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/"},"author":{"name":"Christian Weigand","@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/#\/schema\/person\/1405236bfeefdc436a77e1cbc1e5a80f"},"headline":"Enhancing Medical Trials: Digital Decentralized Clinical Trials","datePublished":"2025-02-05T17:50:53+00:00","dateModified":"2025-02-05T18:05:02+00:00","mainEntityOfPage":{"@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/"},"wordCount":867,"commentCount":0,"publisher":{"@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/#organization"},"image":{"@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-content\/uploads\/2025\/02\/MobileHealthLab.png","articleSection":["Digital Health","Medical Data Space"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/","url":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/","name":"Enhancing Medical Trials: Digital Decentralized Clinical Trials - SMART SENSING insights","isPartOf":{"@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/#website"},"primaryImageOfPage":{"@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-content\/uploads\/2025\/02\/MobileHealthLab.png","datePublished":"2025-02-05T17:50:53+00:00","dateModified":"2025-02-05T18:05:02+00:00","description":"Decentralized clinical trials streamline market approval for medical products. Why? Have a look at the key advantages of DCTs.","breadcrumb":{"@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/#primaryimage","url":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-content\/uploads\/2025\/02\/MobileHealthLab.png","contentUrl":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-content\/uploads\/2025\/02\/MobileHealthLab.png","width":4168,"height":2085,"caption":"illustration of decentralized clinical trials"},{"@type":"BreadcrumbList","@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/decentralized-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/"},{"@type":"ListItem","position":2,"name":"Enhancing Medical Trials: Digital Decentralized Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/#website","url":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/","name":"SMART SENSING insights","description":"learn more about our focus research areas sensor technology, electronics, and artificial intelligence","publisher":{"@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/#organization","name":"Fraunhofer IIS","url":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/#\/schema\/logo\/image\/","url":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-content\/uploads\/2023\/06\/Fraunhofer-IIS-1.png","contentUrl":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-content\/uploads\/2023\/06\/Fraunhofer-IIS-1.png","width":826,"height":299,"caption":"Fraunhofer IIS"},"image":{"@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/FraunhoferIIS","https:\/\/www.linkedin.com\/company\/fraunhofer-iis"]},{"@type":"Person","@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/#\/schema\/person\/1405236bfeefdc436a77e1cbc1e5a80f","name":"Christian Weigand","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-content\/uploads\/2023\/08\/Weigand-Christian-0907-Glasow_1zu1-scaled-96x96.jpga850c8def151022934da8ec6725bb4c8","url":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-content\/uploads\/2023\/08\/Weigand-Christian-0907-Glasow_1zu1-scaled-96x96.jpg","contentUrl":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-content\/uploads\/2023\/08\/Weigand-Christian-0907-Glasow_1zu1-scaled-96x96.jpg","caption":"Christian Weigand"},"description":"Christian is an expert in computer science and digital health, specialized in interoperability of medical devices, DiGA \/ DTx applications, and hospital information systems. He is head of the Fraunhofer IIS Mobile Health Lab. He has previously served as CTO at the Medical Valley Digital Health Application Center (dmac) for 6 years. Further affiliations include the National Coordination Office for Interoperability @gematik \/ Interop Council, DGBMT working group mHealth, and the Cybermed expert group at the Alliance for Cybersecurity.","sameAs":["https:\/\/orcid.org\/0000-0002-7542-994X","https:\/\/www.linkedin.com\/in\/christian-weigand-7b710993\/"],"url":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/author\/christian-weigand\/"}]}},"_links":{"self":[{"href":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-json\/wp\/v2\/posts\/3165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-json\/wp\/v2\/comments?post=3165"}],"version-history":[{"count":32,"href":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-json\/wp\/v2\/posts\/3165\/revisions"}],"predecessor-version":[{"id":3288,"href":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-json\/wp\/v2\/posts\/3165\/revisions\/3288"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-json\/wp\/v2\/media\/3234"}],"wp:attachment":[{"href":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-json\/wp\/v2\/media?parent=3165"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-json\/wp\/v2\/categories?post=3165"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-json\/wp\/v2\/tags?post=3165"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/websites.fraunhofer.de\/smart-sensing-insights\/wp-json\/wp\/v2\/coauthors?post=3165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}